Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-day regimen of oseltamivir for postexposure prophylaxis
jRCTs011180015Completed
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oseltamivir in influenza. Primary endpoint: Occurrence of influenza infection after three-day oseltamivir post-exposure prophylaxis. Started Dec 2016; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on jRCTs011180015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011180015.